COMP <GO>
ICLR vs MRK // ALTMAN Z-SCORE & DEBT/EQUITY
ICON plc (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: ICLR 3
— MRK 11
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: MRK
LAST: $211.36 (-1.91%) • MKT CAP: $16.50B
balance-sheet
2.20
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
balance-sheet
5.19
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICLR VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ICLR | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 20.70% | -17.60 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 31.7x | 15.3x | +16.40 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 5.22% | 3.42% | +1.80 | ICLR | /fcf-yield <GO> |
| Operating Margin | 5.40% | 34.30% | -28.90 | MRK | /operating-margins <GO> |
| Net Profit Margin | 2.80% | 28.10% | -25.30 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 0.80% | 1.30% | -0.50 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.20 | 5.19 | -2.99 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.60% | +0.60 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.1 | 56.9 | +17.21 | ICLR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.92 | +0.16 | ICLR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 66.9x | 18.4x | +48.50 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.50B | $361.02B | -$344.52B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ICLR REV | MRK REV | ICLR GROSS % | MRK GROSS % | ICLR FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.25B | $65.01B | 44.0% | 74.8% | $862.0M | $12.36B |
| FY 2024 | $8.19B | $64.17B | 28.6% | 76.3% | $1.12B | $18.10B |
| FY 2023 | $8.05B | $60.12B | 44.0% | 44.0% | $798.6M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICLR // BETA 1.08
MRK // BETA 0.92